When managing complex chronic dermatologic diseases, efforts to incorporate alternative treatments can add efficacy, patient ...
The US Food and Drug Administration (FDA) has approved nemolizumab for moderate-to-severe atopic dermatitis inadequately ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback